Europe Diet Pills Market
Europe Diet Pills Market Analysis By Drug Class (Lipase Inhibitors, Choline, Glucomannan, Garcinia Cambogia), By Drug Type (Prescription Drugs, OTC Drugs, Herbal Supplements), By Mechanism, By Distribution Channel & By Region - Global Insights to 2031
Analysis of Europe Diet Pills Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Outlook for Europe Diet Pills
Newly released data in Fact.MR’s market analysis shows that demand for diet pills in Europe is expected to increase at a CAGR of 2.6% through 2031, with the market being valued at US$ 669 Mn currently.
Sales of glucomannan drugs are expected to grow from US$ 258.1 Mn in 2020 to around US$ 361.2 Mn by 2031, while those of herbal supplements from US$ 455.1 Mn to around US$ 611.6 Mn.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Detailed Insights Offered in Europe Diet Pills Industry Survey:
- Market Estimates and Forecasts (2016 to 2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Sales of Diet Pills in 2020 and Beyond and How to Navigate
- Recommendation on Key Winning Strategies
Sales Analysis of Diet Pills in Europe from 2016 to 2020 Vs Market Outlook for 2021 to 2031
Market growth in terms of CAGR from 2016 to 2020 for diet pills in Europe has been observed a 0.7%, wherein, glucomannan had the highest market share of 39.5%in 2020.
More number of customers are inclining towards dietary supplements such as diet pills in their daily dietary habits. Moreover, customers across the U.K. and Germany, where cases of obesity are rising at a fast pace, are adopting preventive measures and focusing on the consumption of dietary supplements.
Increasing health awareness among customers and rising willingness to spend on dietary supplements and nutrition are driving demand for diet pills as an appetite suppressant across the continent. Additionally, development of distribution channels for diet pills is leading to better accessibility, which is also expected to boost market growth.
In addition, growing geriatric population and rising healthcare costs throughout Europe are anticipated to support the market in gaining significant traction over the coming years.
Considering these statistics and shift in dynamics for demand for diet pills as a fat blocker, over the forecast period of 2021 to 2031, the market is expected to expand at around 2.6% CAGR.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What are the Key Opportunities Ahead for European Diet Pill Manufacturers?
Opportunity for key players for increased sales of fat blocker diet pills exists with rising awareness. Manufacturers involved in the development of diet pills are focusing on the development of highly advanced medicines that can satisfy end users. Most studies reveal that people who want to look and feel healthier seek more options in addition to just diet and exercise.
Increasing prevalence of cardiovascular diseases, rising cholesterol levels, and surging lifestyle diseases are also some of the key factors that are contributing to the increase in the number of consumers looking for weight loss supplements, thereby complementing the sales of diet pills for appetite control.
What is the Main Restraining Factor for Diet Pill Suppliers in Europe?
Higher cost involved in drug development of prescription obesity drugs is a great challenge for manufacturers of diet pills. Moreover, prolonged time required for drug development activities and also need for intensive clinical trials to test drugs add to the expenditure.
Thus, manufacturers of metabolism raising diet pills must stay cautious and ensure investments in markets that can provide better return on investments. Restrictions posed by higher R&D of obesity drugs will hinder market growth to some extent.
Limited availability of approved drugs has resulted in large-scale adoption of off-label drugs, which means, prescribed class of drugs are effective in the treatment of obesity but not approved by regulatory authorities as an actual drug to treat the condition. Thus, widespread adoption of off-label drugs limits the penetration of actual drugs, subsequently restraining market.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
How is Increasing Prevalence of Obesity and Associated Comorbidities Impacting Demand for Diet Pills for Appetite Suppression?
Growing incidence of obesity is a major challenge to disease prevention across the globe. It is estimated that obesity is a major public health problem in Europe. For instance, in 2016, according to Eurostat data, obesity affects 10%-30% of adults, and overweight affects 30%-70% adults in European Union countries.
Weight loss with both, prescription-based diet pills and over-the-counter diet pills play a vital role in the treatment of highly critical obesity and diseases associated with it, such as diabetes, hypertension, and sleep apnea.
Cases of obesity among adolescents and children aged 5-19 have grown dramatically from just 4% in 1975 to over 18% in 2016. This shows that prevalence of obesity has nearly tripled between 1975 and 2016.
Thus, rising incidence of obesity and related medical conditions will lead to growing adoption of drugs for weight loss and obesity, which will accelerate demand for weight loss pills.
Country-wise Analysis
Why is Demand for Diet Pills Surging across the U.K.?
According to projections by Fact.MR, the market in the U.K. is expected to observe lucrative growth of over the forecast period with a value of approx. US$ 193 Mn by 2031.
In the U.K., around 29% of adults were categorized as obese by the World Health Organization (WHO) in 2017, growing from 26% in 2016. Owing to this, people in the country have increased the consumption of dietary supplements.
Customers here have better access to knowledge about nutrition and health, owing to social media, lifestyle blogs, and active media telecasts. In addition, key players are increasing investments in new product development and advertising, which, consequently, boosts demand for diet pills in the country.
Furthermore, e-Commerce platforms aid market growth at an incredible rate due to the ability to access different brands and for the convenience that it provides.
What Allows Germany to Lead the Diet Suppressants Market in Western Europe?
Sales of diet suppressants in Germany are expected to experience lucrative growth and progress at a CAGR of around 3%. Major factor driving this market is rising concerns about health and increasing deficiency levels in the country.
The German market for diet pills is developing at a steady rate as customers have become more aware about health and are ready to spend on products that are observed as advantageous. Particularly, customers who don’t follow a balanced diet are choosing dietary supplements to the prevent deficiency of essential nutrients.
Also, the trend of self-medication is increasing in Germany due to rising awareness about nutrition deficiency-related disorders and over-the-counter products.
Category-wise Insights
Which Drug Class of Diet Pills Witnesses High Demand in Europe?
Glucomannan accounted for the largest market share of 39.5% in 2020, owing to its effectiveness for appetite suppression.
Glucomannan is a water-soluble, natural dietary fiber extracted from elephant yam roots, called konjac. It absorbs a lot of liquid; a little amount of glucomannan poured to a glass of water turns the total contents into a gel.
These exceptional properties are believed to popularize its use for weight loss. It is different from other soluble fibers, because it is extremely viscous, making it specifically effective for weight loss.
Why is Demand for Herbal Supplements High across Europe?
Herbal diet pills (supplements) represented the largest market share and accounted for a revenue of US$ 444.3 Mn in 2020, prompted by increase in use of organically obtained products.
Herbal supplements are natural supplements added to a diet for enhancing cardiovascular health, immunity, digestion, etc. These products are protective in nature and help prevention of disease rather than concentrating on the cure.
Other dietary supplements include minerals and vitamins (such as multivitamin or a vitamin C). In contrast, herbal supplements are extracted from botanicals (plant and herbs products) and substances that are obtained from a natural source.
How Has COVID-19 Impacted Sales of Diet Pills in the European Market?
In January 2020, the World Health Organization (WHO) declared COVID-19 pandemic as a world health emergency. The pandemic emergency is challenging governments to execute monetary measures and fiscal policies that sustain economic activity and support credit markets.
Because of the COVID-19 pandemic, the diet pills industry in Europe improved among various pockets as maximum of European customers increased their interest on overall wellness and health.
For example, the outbreak of COVID-19 in March 2020 in Poland had a remarkable effect on buying patterns that transformed into volume of product sales. From February to March, the largest sales rise was recorded for products from the health industry, such as OTC drugs, thereby benefiting the dietary supplements market.
Competitive Landscape
Key players are focusing on expansion in emerging countries and introducing features in their product lines. Various manufacturers are spending on developing integrated software that can include cutting-edge technologies to understand the formulation of diet pills.
Market players are also engaged in expanding their regional presence through acquisitions, collaborations, expansions, product launches, and improvement of distribution channels.
- In September 2019, Currax™ Pharmaceuticals LLC announced the acquisition of Nalpropion Pharmaceuticals, Inc. Currax now owns the worldwide rights to CONTRAVE, which is the number one prescribed weight-loss brand medication.
- In June 2020, Holland & Barrett and Deliveroo announced a new partnership to deliver a selected range of more than 200 products from 50 stores across the U.K.
- In September 2018, Nature's Way Products, LLC and Natural Products Canada entered into a new investment agreement for investing in new companies working in natural products sectors such as supplements and dietary ingredients.
Europe Diet Pills Market Report Scope
| Report Attribute | Details |
|---|---|
| Forecast Period | 2021-2031 |
| Historical Data Available for | 2016-2020 |
| Market Analysis | USD Million for Value; Volume (Units); Pricing Analysis |
| Key Regions Covered |
Europe |
| Key Countries Covered | Germany, U.K., France, Italy, Spain, Benelux, Russia |
| Key Market Segments Covered | Drug Class; Drug Type; Mechanism; Distribution Channel |
| Key Companies Profiled | GlaxoSmithKline plc.; Cheplapharm Arzneimittel GmbH; Holland & Barrett Retail Limited; Cresent Pharma.; Currax Pharmaceuticals LLC (OREXIGEN THERAPEUTICS IRELAND LTD); Himalaya Wellness (The Himalaya Drug Company); Nature's Way Products, LLC; zeinpharma; SimplySupplements; Lindens Health + Nutrition |
| Report Coverage | Market Forecasts, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics, Challenges, Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
Segments Covered Europe Diet Pills Industry Research
-
By Drug Class :
- Lipase Inhibitors
- Choline
- Glucomannan
- Garcinia Cambogia
- Others
-
By Drug Type :
- Prescription Drugs
- OTC Drugs
- Herbal Supplements
-
By Mechanism :
- Metabolism Raising Diet Pills
- Fat Blocking Diet Pills
- Appetite Controlling Diet Pills
- Others
-
By Distribution Channel :
- Diet Pills Sold at Hospital Pharmacies
- Diet Pills Sold at Retail Pharmacies
- Diet Pills Sold at Clinics
- Online Sales of Diet Pills (e-Commerce)
- Stores
- Amazon
- Pharmacies
- Sales of Diet Pills by Drug Stores
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Key Success Factors
- 5. Market Background
- 6. Europe Market Demand Volume (Units) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 7. Europe Market - Pricing Analysis
- 8. Europe Market Value (US$ Mn) Analysis 2016 to 2020 and Forecast, 2021 to 2031
- 9. Europe Market and Volume Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
- 9.1. Lipase Inhibitors
- 9.2. Choline
- 9.3. Glucomannan
- 9.4. Garcinia Cambogia
- 9.5. Others
- 10. Europe Market and Volume Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
- 10.1. Prescription Drugs
- 10.2. OTC Drugs
- 10.3. Herbal Supplements
- 11. Europe Market and Volume Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
- 11.1. Metabolism Raising Pills
- 11.2. Fat Blocking Pills
- 11.3. Appetite Controlling Pills
- 11.4. Others
- 12. Europe Market and Volume Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
- 12.1. Hospital Pharmacies
- 12.2. Retail Pharmacies
- 12.3. Clinics
- 12.4. e-commerce
- 12.4.1. Stores
- 12.4.2. Amazon
- 12.4.3. Pharmacies
- 12.5. Drug Stores
- 13. UK Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 14. Germany Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 15. Italy Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 16. France Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 17. Spain Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 18. BENELUX Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 19. Russia Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 20. Rest of Europe Market Analysis 2016 to 2020 and Forecast 2021 to 2031
- 21. Competition Analysis
- 21.1. GlaxoSmithKline plc
- 21.2. Cheplapharm Arzneimittel GmbH
- 21.3. Currax Pharmaceuticals LLC (OREXIGEN THERAPEUTICS IRELAND)
- 21.4. Cresent Pharma
- 21.5. Himalaya Wellness
- 21.6. Holland & Barrett
- 21.7. Lindens
- 21.8. Natures Way
- 21.9. Zeinpharma
- 21.10. SimplySuppliments
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: U.K. Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 02: U.K. Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 03: U.K. Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 04: U.K. Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 05: U.K. Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 06: U.K. Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 07: U.K. Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 08: U.K. Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 09: U.K. Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 10: U.K. Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 11: U.K. Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 12: U.K. Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 13: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 14: Germany Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 15: Germany Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 16: Germany Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 17: Germany Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 18: Germany Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 19: Germany Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 20: Germany Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 21: Germany Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 22: Germany Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 23: Germany Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 24: Germany Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 25: Germany Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 26: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 27: Italy Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 28: Italy Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 29: Italy Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 30: Italy Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 31: Italy Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 32: Italy Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 33: Italy Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 34: Italy Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 35: Italy Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 36: Italy Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 37: Italy Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 38: Italy Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 39: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 40: France Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 41: France Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 42: France Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 43: France Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 44: France Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 45: France Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 46: France Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 47: France Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 48: France Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 49: France Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 50: France Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 51: France Garcinia Cambodia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 52: Others: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 53: Spain Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 54: Spain Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 55: Spain Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 56: Spain Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 57: Spain Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 58: Spain Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 59: Spain Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 60: Spain Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 61: Spain Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 62: Spain Choline: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 63: Spain Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 64: Spain Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 65: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 66: BENELUX Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 67: BENELUX Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 68: BENELUX Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 69: BENELUX Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 70: BENELUX Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 71: BENELUX Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 72: BENELUX Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 73: BENELUX Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 74: BENELUX Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 75: BENELUX Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 76: BENELUX Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 77: BENELUX Garcinia Cambodia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 78: Others: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 79: Russia Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 80: Russia Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 81: Russia Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 82: Russia Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 83: Russia Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 84: Russia Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 85: Russia Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 86: Russia Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 87: Russia Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 88: Russia Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 89: Russia Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 90: Russia Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 91: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 92: Rest of Europe Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Class
Table 93: Rest of Europe Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Class
Table 94: Rest of Europe Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Drug Type
Table 95: Rest of Europe Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Drug Type
Table 96: Rest of Europe Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Mechanism
Table 97: Rest of Europe Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Mechanism
Table 98: Rest of Europe Diet Pills Demand (in Volume (Mn Pills/tablets/capsules)) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 99: Rest of Europe Market Value ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031 By Distribution Channel
Table 100: Rest of Europe Lipase Inhibitors: Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 101: Rest of Europe Choline : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 102: Rest of Europe Glucomannan : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 103: Rest of Europe Garcinia Cambogia : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
Table 104: Others : Market Size ($ Mn) Analysis 2016 to 2020 and Forecast 2021 to 2031, By Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: U.K. Market Size ($ Mn) Analysis, 2016 to 2020
Figure 02: U.K. Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 03: U.K. Market Value Share 2021E, By Drug Class
Figure 04: U.K. Market Value Share 2021E, By Mechanism
Figure 05: U.K. Market Value Share 2021E, By Drug Type
Figure 06: U.K. Market Value Share 2021E, By Distribution Channel
Figure 07: U.K. Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 08: U.K. Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 09: U.K. Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 10: U.K. Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 11: Germany Market Size ($ Mn) Analysis, 2016 to 2020
Figure 12: Germany Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 13: Germany Market Value Share 2021E, By Drug Class
Figure 14: Germany Market Value Share 2021E, By Mechanism
Figure 15: Germany Market Value Share 2021E, By Drug Type
Figure 16: Germany Market Value Share 2021E, By Distribution Channel
Figure 17: Germany Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 18: Germany Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 19: Germany Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 20: Germany Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 21: Italy Market Size ($ Mn) Analysis, 2016 to 2020
Figure 22: Italy Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 23: Italy Market Value Share 2021E, By Drug Class
Figure 24: Italy Market Value Share 2021E, By Mechanism
Figure 25: Italy Market Value Share 2021E, By Drug Type
Figure 26: Italy Market Value Share 2021E, By Distribution Channel
Figure 27: Italy Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 28: Italy Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 29: Italy Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 30: Italy Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 31: France Market Size ($ Mn) Analysis, 2016 to 2020
Figure 32: France Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 33: France Market Value Share 2021E, By Drug Class
Figure 34: France Market Value Share 2021E, By Mechanism
Figure 35: France Market Value Share 2021E, By Drug Type
Figure 36: France Market Value Share 2021E, By Distribution Channel
Figure 37: France Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 38: France Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 39: France Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 40: France Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 41: Spain Market Size ($ Mn) Analysis, 2016 to 2020
Figure 42: Spain Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 43: Spain Market Value Share 2021E, By Drug Class
Figure 44: Spain Market Value Share 2021E, By Mechanism
Figure 45: Spain Market Value Share 2021E, By Drug Type
Figure 46: Spain Market Value Share 2021E, By Distribution Channel
Figure 47: Spain Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 48: Spain Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 49: Spain Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 50: Spain Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 51: BENELUX Market Size ($ Mn) Analysis, 2016 to 2020
Figure 52: BENELUX Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 53: BENELUX Market Value Share 2021E, By Drug Class
Figure 54: BENELUX Market Value Share 2021E, By Mechanism
Figure 55: BENELUX Market Value Share 2021E, By Drug Type
Figure 56: BENELUX Market Value Share 2021E, By Distribution Channel
Figure 57: BENELUX Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 58: BENELUX Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 59: BENELUX Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 60: BENELUX Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 61: Russia Market Size ($ Mn) Analysis, 2016 to 2020
Figure 62: Russia Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 63: Russia Market Value Share 2021E, By Drug Class
Figure 64: Russia Market Value Share 2021E, By Mechanism
Figure 65: Russia Market Value Share 2021E, By Drug Type
Figure 66: Russia Market Value Share 2021E, By Distribution Channel
Figure 67: Russia Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 68: Russia Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 69: Russia Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 70: Russia Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Figure 71: Rest of Europe Market Size ($ Mn) Analysis, 2016 to 2020
Figure 72: Rest of Europe Market Size ($ Mn) Forecast & Y-o-Y Growth (%), 2021 to 2031
Figure 73: Rest of Europe Market Value Share 2021E, By Drug Class
Figure 74: Rest of Europe Market Value Share 2021E, By Mechanism
Figure 75: Rest of Europe Market Value Share 2021E, By Drug Type
Figure 76: Rest of Europe Market Value Share 2021E, By Distribution Channel
Figure 77: Rest of Europe Market Attractiveness Analysis By Drug Class, 2021 to 2031
Figure 78: Rest of Europe Market Attractiveness Analysis By Drug Type, 2021 to 2031
Figure 79: Rest of Europe Market Attractiveness Analysis By Mechanism, 2021 to 2031
Figure 80: Rest of Europe Market Attractiveness Analysis By Distribution Channel, 2021 to 2031
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the diet pills market valued at in Europe?
The Europe diet pills market is worth US$ 669 Mn at present, on the back of increasing prevalence of obesity, rising health awareness, and growing healthcare expenditure.
What will be the demand outlook for diet pills across Europe?
Demand for diet pills across Europe is projected to reach a value of US$ 868 Mn by 2031, with glucomannan holding the highest market share.
At what rate did the European diet pills expand over the past 5 years?
Historically, the market in Europe progressed at a CAGR of around 1%.
What are the key trends related to diet pills across the European continent?
New product launches, mergers and agreements for expansion in emerging markets, rise in healthcare spending, and increasing consumer awareness regarding preventive health are major market trends.
What is mainly driving demand for diet pills across the European region?
Increasing consumption of diet pills in emerging countries, increasing prevalence of obesity and associated comorbidities, and rising number of manufacturers are complementing market growth.
What is the market share of the top 5 suppliers of diet pills in Europe?
Top 5 manufacturers of diet pills in Europe hold around 20%-25% market share.
What are the top countries driving demand diet pills in Europe?
The U.K., Germany, and Italy are the top 3 countries driving demand for diet pills in Europe.
At what percentage is the weight loss pills market expected to register growth in the U.K.?
The U.K. market for diet pills is set to exhibit a CAGR of 3.6%, owing to rising e-Commerce platforms and increase in consumption of dietary supplements
Which countries in Europe are key producers of diet pills?
The U.K. and Germany are key countries in Europe involved in the manufacturing of diet pills.
What are the key market statistics for Italy and Russia?
After Germany, Italy is the next leading country in Europe and is expected to hold a market share of 14.2% by 2031.
Europe Diet Pills Market